Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene
Authors: Liljana Petrovska; Richard J. Aspinall; Li Barber1; Simon Clare1; Cameron P. Simmons1; Richard Stratford2; Shahid A. Khan2; Nicholas R. Lemoine3; Gad Frankel1; David W. Holden1; Gordon Dougan1
Source: Cellular Microbiology, Volume 6, Number 11, November 2004 , pp. 1071-1084(14)
Publisher: Blackwell Publishing
Abstract:
Summary Salmonella enterica serovar Typhimurium (S. Typhimurium) and several mutant derivatives were able to enter efficiently murine bone marrow-derived dendritic cells using mechanisms predominantly independent of the Salmonella pathogenicity island 1 type III secretion system. The levels of intracellular bacteria did not increase significantly over many hours after invasion. Using fluid endocytic tracers and other markers, S. Typhimurium-containing vacuoles (SCVs) were physically distinguishable from early endocytic compartments. Fifty to eighty per cent of SCVs harbouring wild-type S. Typhimurium or aroA, invH and ssaV mutant derivatives were associated with late endosome markers. In contrast, S. Typhimurium sifA was shown to escape the SCVs into the cytosol of infected dendritic cells. S. Typhimurium aroC sifA was more efficient than S. Typhimurium aroC in delivering a eukaryotic promoter-driven green fluorescent protein reporter gene for expression in dendritic cells. In contrast, S. Typhimurium aroC sifA did not detectably increase the efficiency of MHC class I presentation of the model antigen ovalbumin to T cells compared to a similar aroC derivative. Mice infected with the S. Typhimurium aroC sifA expressing ovalbumin did not develop detectably enhanced levels of cytotoxic T cell or interferon-
production compared to S. Typhimurium aroC derivatives.
Document Type: Research article
DOI: 10.1111/j.1462-5822.2004.00419.x
Affiliations: 1: Centre for Molecular Microbiology and Infection, Department of Biological Sciences, Imperial College London, Exhibition Road, London SW7 2AZ, UK. 2: Miroscience, Winnersh Triangle, Wokingham, Berks, RG41 5T, UK. 3: Cancer Research UK, Molecular Oncology Unit, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.

Click here for Page Help